News
Important Only
If You Buy Palantir Stock With $20,000 in 2025, Will You Be a Millionaire in 10 Years?
Palantir Technologies (NASDAQ: PLTR) is one of the most heavily traded tickers on the U.S. market. The stock is especially popular among retail investors, many of whom admire CEO Alex Karp for his blunt language and brutal honesty. In turn, Karp has often said the retail crowd understands Palantir b...The Motley Fool
Sat, Apr 26
The Nasdaq-100 Just Did Something for Only the 10th Time in 23 Years -- and It Has a 91% Success Rate of Forecasting Future Stock Moves
When examined with a wide lens, stocks have outdone all other asset classes in the return column. But this doesn't mean the stock market doesn't hit speed bumps or endure rough patches.Following a period of seemingly unbridled optimism that began in October 2022, Wall Street has hit one of these rou...The Motley Fool
Sat, Apr 26
The S&P 500 Just Did Something That's Only Happened 20 Times in 82 Years -- and It Has a 100% Success Rate in Predicting Which Direction Stocks Will Move Next.
The S&P 500 (SNPINDEX: ^GSPC) includes the 500 largest companies in the U.S. and is the most widely followed benchmark of stock market activity in the country. Because it represents such a broad cross-section of American businesses, it's widely considered to be the most dependable gauge of overall s...The Motley Fool
Sat, Apr 26
51Talk Online Education Group Files Annual Report on Form 20-F for Fiscal Year of 2024
SINGAPORE, April 26, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced that it filed its annual report on Form 20-F for the fi...PR Newswire
Sat, Apr 26
CORRECTED (OFFICIAL)-Balchem Corp reports results for the quarter ended March 31 - Earnings Summary
By Lynx Insight ServiceBalchem Corp BCPC.OQ reported quarterly adjusted earnings of $1.22 per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $1.03. The mean expectation of three analysts for the quarter was for earnings of $1.22 per ...Reuters
Sat, Apr 26
Galloway Capital builds 3% WW stake, pushes for debt deal amid bankruptcy rumors
Investing.com – Galloway Capital Partners (WA:CPAP) is urging WW International Inc (NASDAQ:WW) to avoid Chapter 11 bankruptcy, after disclosing a 2.87% stake in the embattled weight management compaInvesting.com
Fri, Apr 25
Why Verizon and AT&T Stocks Fizzled on Friday
Concerns about a top rival's performance put big telecoms Verizon (NYSE: VZ) and AT&T (NYSE: T) in the investor doghouse on Friday. The stocks of both companies traded limply, to the point where the pair closed the day more than 2% lower in price. That made them outliers, as the S&P 500 index inched...The Motley Fool
Fri, Apr 25
Why Landstar System Stock Flopped on Friday
Logistics specialist Landstar System (NASDAQ: LSTR) wasn't looking like such a special company to investors as the trading week came to a close. Its share price decelerated by almost 4% on Friday on news of a reporting delay. That decline was particularly noticeable given that the benchmark S&P 500 ...The Motley Fool
Fri, Apr 25
Autodesk: A Strong Player in Engineering Software, but Is It Safe?
Explore the exciting world of Autodesk (NASDAQ: ADSK) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were the prices of March 19, 2025. The video was pub...The Motley Fool
Fri, Apr 25
Why Compass Pathways Stock Was a Double-Digit Winner This Week
The field of psychedelic medicine is relatively new, and because of this, certain investors consider it to be loaded with potential. That's why even minor events in companies specializing in this can be greeted with notable share price pops.Such a dynamic was in evidence with U.K.-based Compass Path...The Motley Fool
Fri, Apr 25
Why Kymera Therapeutics Stock Crushed it This Week
According to data compiled by S&P Global Market Intelligence, Kymera Therapeutics (NASDAQ: KYMR) notched an almost 23% share price gain across this week. That made it a standout in the ever-volatile biotech sector. Investors were cheered by a pair of announcements published by the company. Patients ...The Motley Fool
Fri, Apr 25
Summit Therapeutics closes 36% lower after interim data for cancer drug
** Shares of Summit Therapeutics SMMT.O settle 36% lower to $23.47 at close, last up 3.81% to $24.36 in after-market trade** Co says in the submission for cancer drug ivonescimab in China by partner Akeso 9926.HK, the regulators asked for an interim analysis of overall survival** The drug was approv...Reuters
Fri, Apr 25
Concord Medical Files Annual Report on Form 20-F for Fiscal 2024
BEIJING, April 26, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report ...PR Newswire
Fri, Apr 25
Nutriband Inc expected to post a loss of 12 cents a share - Earnings Preview
Nutriband Inc NTRB.OQ NTRB.O is expected to report resultson April 28 (estimated) for the period ending January 31 2025The Orlando Florida-based company is expected to report revenue of $710 thousand, according to the estimate from one analyst, based on LSEG data.LSEG's mean analyst estimate f...Reuters
Fri, Apr 25
Why Root Stock Zoomed Almost 26% Higher This Week
One of the better-performing financial stocks over the past few days hasn't been a famous bank or a prominent credit card company. Booking a share price gain of nearly 26% over the course of this week, according to data compiled by S&P Global Market Intelligence, was insurance company Root (NASDAQ: ...The Motley Fool
Fri, Apr 25
Why Solana, Cardano, and Sui Were Up Big This Week
Altcoins were hot this week as investors poured back into the crypto market after a major sell-off early in April.The biggest move came from Sui (CRYPTO: SUI), which has been gaining momentum from users this year, and jumped 68.4% this week. Solana (CRYPTO: SOL) was up 13% on the week, Cardano (CRYP...The Motley Fool
Fri, Apr 25
Why AbbVie Stock Topped the Market Today
A pair of convincing quarterly earnings beats -- not to mention a profitability guidance raise -- made AbbVie (NYSE: ABBV) stock an investor darling on Friday. The pharmaceutical company's performance pushed its stock to a more than 3% gain on the day, well higher than the 0.6% bump of the bellwethe...The Motley Fool
Fri, Apr 25
The Smartest Growth Stock to Buy With $20 Right Now
Growth stocks have taken a hit in the market so far this year as investors have entered risk-off mode, thanks to the economic uncertainty caused by the ongoing tariff-fueled trade war. However, the good part is that the stock market sell-off has brought the valuations of some fast-growing companies ...The Motley Fool
Fri, Apr 25
DIARY-Federal Reserve Events
***Denotes a new entry. -------------------------------------------------------- Federal Open Market Committee (FOMC) MEETING DATES: 2025May 6-7 (second day: statement released 1400 EDT/1800 GMT; news conference expected 1430 EDT/1830 GMT)June 17-18 (second day: statement released 1400 EDT/1800 ...Reuters
Fri, Apr 25
Why Biohaven Stock Plummeted by More Than 15% Today
On Friday's news that Biohaven (NYSE: BHVN) withdrew its application for a top investigational drug from an important regulator, investors aggressively traded out of the stock. The clinical-stage biotech was one of the biggest decliners in its industry, exiting Friday with a share price decline of o...The Motley Fool
Fri, Apr 25
